Indium-111 pentetreotide scintigraphy (SPECT/CT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Indium-111 pentetreotide scintigraphy (SPECT/CT), covering 2016-09-07 to 2016-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors [Phase 1, Phase 2]